Abstract
Community acquired pneumonia (CAP) is among the leading causes of death worldwide. Despite intense research in the field and the development of new therapies, mortality remains largely unaltered for the past three decades. Antimicrobial agents are the cornerstone of therapy against CAP, but sometimes despite early diagnosis and the initiation of antibiotics, mortality remains high. A possible explanation may be due to several other host-related factors that keep the septic reaction intense. Part of this intensity may be attributed to the host-pathogen interaction and the deterioration of the host that is evoked by an immunologic overreaction. There is substantial evidence that macrolides have an inmunomodulatory effect on the host immune response, with multiple observational and prospective studies supporting a significant increased survival rate in patients with CAP treated with macrolides. We will review the significance of this non-antimicrobial effect of macrolides for the management of CAP.
Keywords: Community-acquired pneumonia, macrolides, immunomodulation, sepsis
Current Respiratory Medicine Reviews
Title: Macrolides in Community-Acquired Pneumonia: The Importance of the Non-Antimicrobial Effect
Volume: 6 Issue: 3
Author(s): Pedro J. Marcos, Grant W. Waterer, Nadia S. Brienza and Pedro Marcos-Velazquez
Affiliation:
Keywords: Community-acquired pneumonia, macrolides, immunomodulation, sepsis
Abstract: Community acquired pneumonia (CAP) is among the leading causes of death worldwide. Despite intense research in the field and the development of new therapies, mortality remains largely unaltered for the past three decades. Antimicrobial agents are the cornerstone of therapy against CAP, but sometimes despite early diagnosis and the initiation of antibiotics, mortality remains high. A possible explanation may be due to several other host-related factors that keep the septic reaction intense. Part of this intensity may be attributed to the host-pathogen interaction and the deterioration of the host that is evoked by an immunologic overreaction. There is substantial evidence that macrolides have an inmunomodulatory effect on the host immune response, with multiple observational and prospective studies supporting a significant increased survival rate in patients with CAP treated with macrolides. We will review the significance of this non-antimicrobial effect of macrolides for the management of CAP.
Export Options
About this article
Cite this article as:
J. Marcos Pedro, W. Waterer Grant, S. Brienza Nadia and Marcos-Velazquez Pedro, Macrolides in Community-Acquired Pneumonia: The Importance of the Non-Antimicrobial Effect, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526175
DOI https://dx.doi.org/10.2174/157339810791526175 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Isolation and Identification of an Angiotensin-I Converting Enzyme Inhibitory Peptide from Yeast (Saccharomyces cerevisiae)
Current Analytical Chemistry Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors
Current Drug Targets - CNS & Neurological Disorders Hemodynamic Monitoring in the Acute Management of Pediatric Heart Failure
Current Cardiology Reviews Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction
Current Pharmaceutical Design ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Psoriatic Arthritis and its Novel Therapeutics
Current Rheumatology Reviews Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
Current Vascular Pharmacology An Unusual Case of Reversible Empty Sella
Endocrine, Metabolic & Immune Disorders - Drug Targets Surfactant Replacement Therapy in Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome
Current Respiratory Medicine Reviews Antivenoms for Snakebite Envenomings
Inflammation & Allergy - Drug Targets (Discontinued) CGRP-Receptor Antagonism in Migraine Treatment
CNS & Neurological Disorders - Drug Targets Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis
Current Drug Targets Current Biological Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design Paclitaxel Formulations: Challenges and Novel Delivery Options
Current Drug Delivery Preface
Current Topics in Medicinal Chemistry A Paradigm Shift in the Development of Anti-Candida Drugs
Current Topics in Medicinal Chemistry Deletion of Endoplasmic Reticulum Stress-Induced CHOP Protects Microvasculature Post-Spinal Cord Injury
Current Neurovascular Research Pindolol Augmentation of Antidepressant Response
Current Drug Targets The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews